CSI Market
Sign In | Register

Orchard Therapeutics Plc (ORTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ORTX Annual Balance Sheets →
A period-by-period view of the balance sheet from Orchard Therapeutics Plc to Sep 30 2022 helps clarify how Sep 30 2023's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent23.47
Marketable Securities, Total MA0.00
Cash & Short-term Investments23.00
Accounts receivable6.19
Notes Receivable, Current1.66
Inventories6.64
Other Current Assets8.23
Prepaid Expense And Other Assets Current2.20
Total Current Assets153.92
Equipment/Property/Plant Net7.13
Intangible Assets0.77
Long-term investments1.30
Financial Instruments0.00
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent12.00
Research And Development Tax Credit Receivable Current8.23
Research And Development Tax Credit Receivable Noncurrent3.37
Operating Lease Right Of Use Asset20.00
Total Assets202.27
Liabilities
Accounts Payable, Current AC3.66
Accrued Liabilities, Current4.13
Notes Payable, Current NO9.43
Other Liabilities, Current35.54
Deferred Revenue, Current DE0.74
Total Current Liabilities49.38
Long-term debt26.30
Total Long-term Debt26.30
Deferred Revenue, Noncurrent DE10.35
Other liabilities, Noncurrent46.13
Accrued Expenses And Other Current Liabilities30.00
Operating Lease Liability Noncurrent16.68
Total Liabilities122.01
Stockholders' Equity
Common Stock Value29.46
Additional Paid In Capital Common Stock994.11
Retained Earnings / Accumulated Deficit-965.92
Accumulated Other Comprehensive Income22.61
Other Equity22.61
Common Stockholder's Equity80.26
Total Stockholder's Equity80.26
Liabilities & Stockholder's Equity202.27
4 historic quarters locked

Sign in to unlock the full Orchard Therapeutics Plc balance sheet history.

Sign In Create Free Account

About Orchard Therapeutics Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-062428

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.